Geode Capital Management’s Bluejay Diagnostics BJDX Stock Holding History
Bought
Maintained
Sold
Other funds holding BJDX
Geode Capital Management's BJDX Position: Q3 2026 in Review
Geode Capital Management opened a new position in Bluejay Diagnostics (BJDX) in Q3 2026: 9,901 shares worth $33.9K. The stake represents ﹤0.01% of the portfolio and ranks #4271 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in BJDX as recently as Q1 2026.
Geode Capital Management first reported a position in BJDX in Q3 2024 and has held it in 4 quarters since. The position peaked at $51.8K in Q1 2026. 13 funds tracked by Wall St. Rank hold BJDX as of Q3 2026.
- Geode Capital Management held 9,901 shares of Bluejay Diagnostics worth $33.9K as of Q3 2026.
- Bluejay Diagnostics was a new Geode Capital Management position in Q3 2026.
- Bluejay Diagnostics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4271 holding.
- Geode Capital Management first reported a position in Bluejay Diagnostics in Q3 2024 and has held it in 4 quarters since.
- Geode Capital Management's Bluejay Diagnostics position peaked at $51.8K in Q1 2026.
- 13 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.